Gut Neuroendocrine Cell Signaling

NIH RePORTER · VA · I01 · · view on reporter.nih.gov ↗

Abstract

Parkinson’s disease (PD) is a progressive neurodegenerative disease that results in severe movement disorders and gastrointestinal symptoms such as gastroparesis and constipation. The cause of PD is unknown and there is no cure for the disease. PD is common in the VA and over 40,000 veterans are treated in VA medical facilities each year. There is evidence that environmental toxins such as the pesticide, rotenone, and the herbicide, Agent Orange, may play a role in causing Parkinson’s disease. Military veterans exposed to Agent Orange have an increased incidence of PD and the Institute of Medicine concluded in its report “Veterans and Agent Orange: Update 2008”, that "exposure to Agent Orange and other herbicides used during the Vietnam War is associated with an increased chance of developing Parkinson's disease." As a result, VA recognized that PD was associated with exposure to Agent Orange during military service. Despite the association between environmental toxin exposure and PD, how environmental toxins cause PD is unknown. The pathological hallmarks of PD are cytoplasmic inclusions known as Lewy bodies in the brain and enteric nervous system. These inclusions are associated with degeneration of dopaminergic neurons in the substantia nigra pars compacta which produces the distinctive disorders of movement and vagal nerve dysfunction. The major component of Lewy pathology is aggregated α-synuclein, a synaptic protein with the propensity to misfold and aggregate. Misfolded α-synuclein plays a critical role in PD pathogenesis and recent evidence supports a model in which propagation of Lewy pathology occurs via cell-to-cell transmission of misfolded α-synuclein onto recipient cells. Misfolded α-synuclein recruits native α-synuclein in the recipient cell and acts as a template or nidus for the development of aggregates that eventually lead to formation of Lewy bodies and ultimately PD. There is evidence that PD starts in the gut before affecting the brain. For example, α-synuclein, which is found in an abnormal form in the brains of PD patients, appears in abnormal form in gut nerves before it appears in the brain. Moreover, cutting the vagus nerve (vagotomy) reduces the risk of developing PD. Nevertheless, understanding how environmental toxins cause the abnormal form of α- synuclein to form in the nervous system of the gut is lacking. Enteroendocrine cells (EECs) are specialized sensory cells in the lining of the gut. In this location, EECs are exposed to food and ingested environmental toxins. We recently made two important discoveries. First, we discovered that EECs connect to nerves, thus providing a direct route from the intestine to the brain. Second, we discovered that EECs express α-synuclein and may be the source of abnormal α-synuclein that could spread to the brain. To investigate this possibility, we will perform proof-of-concept studies to characterize α-synuclein in EECs using a model of EECs in vitro, intestinal organoids that...

Key facts

NIH application ID
10045947
Project number
5I01BX002230-07
Recipient
DURHAM VA MEDICAL CENTER
Principal Investigator
Rodger A. Liddle
Activity code
I01
Funding institute
VA
Fiscal year
2021
Award amount
Award type
5
Project period
2014-04-01 → 2022-09-30